1-Methoxy-9-methylcarbazole | 128141-08-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-Methoxy-9-methylcarbazole
• 英文别名: 1-methoxy-9-methyl-9H-carbazole
• CAS: 128141-08-2
• 化学式: C₁₄H₁₃NO
• 分子量: 211.263
• InChiKey: PJHUZVNLIAPKQM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  14.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  3-N-Methylanilino cyclohexene 在 mercury(II) diacetate 、 溶剂黄146 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 xylene 为溶剂， 反应 36.0h， 生成 1-Methoxy-9-methylcarbazole
  参考文献：
  名称：

  汞（II）介导的2-环己基-2'-烯基-N-甲基苯胺的杂环化

  摘要：

  在乙酸存在下，将乙酸中的2- [2'-环己烯基] -N-甲基苯胺与乙酸汞（II）环合，以优异的收率得到1-αIkoxy-1、2、3、4-四氢咔唑。

  DOI：

  10.1016/s0040-4039(00)88767-5

文献信息

• [EN] NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] NOUVEAUX COMPOSES TRICYCLIQUES UTILES POUR TRAITER LES TROUBLES INFLAMMATOIRES ET ALLERGIQUES, PROCEDE DE PREPARATION DE CES COMPOSES ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：GLENMARK PHARMACEUTICALS LTD

  公开号：WO2004037805A1

  公开（公告）日：2004-05-06

  The present invention relates to novel tricyclic compounds useful for the treatment of inflammatory conditions, diseases of the central nervous and insulin resistant diabetes.

  本发明涉及用于治疗炎症性疾病、中枢神经系统疾病和胰岛素抵抗性糖尿病的新型三环化合物。
• Synthesis of 1-alkoxy-1,2,3,4-tetra-hydrocarbazoles by mercury(II) mediated heterocyclization of 2-cyclohex-2′-enyl-<i>N</i>-alkylanilines
  作者：K. C. Majumdar、U. Das

  DOI：10.1139/v96-175

  日期：1996.8.1

  high yields by the mercury(II) mediated heterocyclization of 2-cyclohex-2′-enyl-N-alkylanilines 2(a–g), which in turn were obtained by the acid-catalyzed amino Claisen rearrangement of 3-N-alkylanilinocyclohexenes 1(a–g). Additional supporting evidence for the structure of product 3 was obtained from chemical transformations. Key words: 1-alkoxy tetrahydrocarbazole, mercury(II) mediated heterocyclization

  标题化合物 3(a-i) 是通过汞 (II) 介导的 2-环己-2'-烯基-N-烷基苯胺 2(a-g) 的杂环化以高产率合成的，而后者又是通过酸获得-催化3-N-烷基苯胺基环己烯1(a-g)的氨基克莱森重排。从化学转化中获得了产品 3 结构的其他支持证据。关键词：1-烷氧基四氢咔唑，汞(II)介导的杂环化，氨基克莱森重排，3-N-甲基苯胺基环己烯。
• ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
  申请人：Universal Display Corporation

  公开号：US20220069241A1

  公开（公告）日：2022-03-03

  A compound of Formula I is disclosed. In the structure of Formula I, ring A and ring B are 5- or 6-membered rings; L 1 , L 2 , L 3 , and Z are each linking groups; a, b, and c are each 0 or 1, and a+b+c=2 or 3; K 1 , K 2 , K 3 , and K 4 are each a direct bond, O, or S; Z 1 to Z 6 and X 1 to X 5 are each C or N; W is a linking group comprising 3 to 5 linking atoms, which can be further substituted; M is Pd or Pt; each R A , R B , R C , R D , R E , R, and R′ is selected from H or a variety of substituents, and can be joined to another substituent for form a ring. Organic light emitting devices, consumer products, formulations, and chemical structures containing the compounds are also disclosed.

  揭示了一种Formula I的化合物。在Formula I的结构中，环A和环B是5或6成员环；L1、L2、L3和Z分别是连接基团；a、b和c分别为0或1，且a+b+c=2或3；K1、K2、K3和K4分别为直接键、O或S；Z1至Z6和X1至X5分别为C或N；W是包含3至5个连接原子的连接基团，可以进一步取代；M为Pd或Pt；每个RA、RB、RC、RD、RE、R和R′均从H或各种取代基中选择，并且可以与另一个取代基结合形成环。还揭示了含有这些化合物的有机发光器件、消费品、配方和化学结构。
• COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING DEVICE
  申请人：KYULUX, INC.

  公开号：US20190016704A1

  公开（公告）日：2019-01-17

  A compound having a structure represented by the following general formula emits delayed fluorescent light, and is useful as a light-emitting material. One or more of R 1 , R 2 , R 3 , R 4 , and R 5 represent a 9-carbazolyl group having a substituent at at least one of 1-position and 8-position, or a 10-phenoxazyl group or 10-phenothiazyl group having a substituent at at least one of 1-position and 9-position. The balance thereof represents a hydrogen atom or a substituent.

  具有以下一般式所表示的结构的化合物发射延迟荧光，可用作发光材料。其中R1、R2、R3、R4和R5中的一个或多个表示具有1-位置和8-位置中至少一处的取代基的9-咔唑基团，或具有1-位置和9-位置中至少一处的取代基的10-苯氧嗪基团或10-苯并噻唑基团。其余部分表示氢原子或取代基。
• Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders:process for their preparation and pharmaceutical compositions containing them
  申请人：Balasubramanian Gopalan

  公开号：US20060178418A1

  公开（公告）日：2006-08-10

  The present invention relates to novel tricyclic compounds useful for the treatment of inflammatory conditions, diseases of the central nervous and insulin resistant diabetes.

  本发明涉及一种新的三环化合物，可用于治疗炎症病症、中枢神经疾病和胰岛素抵抗性糖尿病。